Remember when lip fillers and Botox seemed taboo? In the early 2000s, celebrities especially seemed to be more guarded about ...

Actavis/Allergan shown by putting separate 2014 company ... while the top 20 companies saw their share of originations drop from 29 per cent to 23 per cent. The global top 20 companies currently ...

Now, there could be another alternative, in the form of eye drops administered daily, according to AbbVie's Allergan subsidiary, which reported new phase 3 data for its pilocarpine formulation ...

Although AbbVie has lost patent exclusivity for its flagship drug, Humira, the company may soon be bigger and better.

Ocufen ®, Allergan (US), 12/86 [received 1/87]). Like corticosteroids, they can also slow healing with prolonged treatment and the effect may be additive. Corneal thinning, erosion, and ...

NORTH CHICAGO, Ill., Jan. 29, 2025 /PRNewswire/ -- In response to growing demand for personalized, patient-centric aesthetic solutions 1,2, Allergan Aesthetics, an AbbVie Company, is proud to unveil ...

A whistleblower lost his bid to reinstate a False Claims Act suit alleging that Allergan Inc. and Adamas Pharmaceuticals Inc. fraudulently obtained patents on two drugs to combat Alzheimer’s disease.